TICAGRELOR
NDC 53401-028, TICAGRELOR, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 53401-028
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208596
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53401-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TICAGRELOR90 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53401-028-42 | 53401002842 | 1800 TABLET in 1 BOTTLE (53401-028-42) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5955a5f5-fbc7-8f67-e063-6394a90ada36
Use it
Look up 53401-028 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53401-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53401-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.